- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04234308
Properties of Absorbable and Nonabsorbable Suture Material in Dental Surgery
Clinical, Mechanical, and Histological Properties of Absorbable and Nonabsorbable Suture Materials Used in Periodontal and Dental Implant Surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Subject must have read, understood and signed the informed consent form. Subject must require either open flap debridement surgery or implant placement (one to three consecutive teeth replacement) surgery.
Subjects must be males or females who are a minimum of 20 years of age. No history of periodontal or implant surgery at the investigational area site within the past 12 months.
Periodontal probing depths ≥5 mm interdentally at the implant site. Subjects that received single interrupted sutures for flap closure following surgical procedures.
Exclusion Criteria:
- Subject is part of a vulnerable population will be excluded. Female subjects who are pregnant or lactating, or who intend to become pregnant during the study period following entrance into the study.
Subjects with a systemic disease that would preclude periodontal surgery. Subjects who are smokers or chew tobacco. Subjects that received periodontal dressing on the surgical area. Subjects with the presence of acute infectious lesions in the areas intended for surgery.
Subjects with conditions or circumstances, in the opinion of the Investigator, which would prevent completion of study participation or interfere with analysis of study results.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Polyglycolic Acid Absorbable suture
Periodontal and periimplant flaps closed with at least one suture with Polyglycolic Acid Absorbable suture, synthetic, 4-0.
(TAGUM®).
|
Periodontal and periimplant flaps closed with at least one suture with Polyglycolic Acid Absorbable suture, synthetic, 4-0.
(TAGUM®).
|
|
Experimental: Chromic Gut Absorbable suture
Periodontal and periimplant flaps closed with at least one suture with Chromic Gut Absorbable suture, natural, 4-0.
(TAGUM®)
|
Periodontal and periimplant flaps closed with at least one suture with Chromic Gut Absorbable suture, natural, 4-0.
(TAGUM®)
|
|
Experimental: ePTFE Non absorbable suture
Periodontal and periimplant flaps closed with at least one suture with ePTFE Non absorbable suture, synthetic, 4-0.
(TAGUM®)
|
Periodontal and periimplant flaps closed with at least one suture with expanded Polytetrafluoroethylene Non absorbable suture, synthetic, 4-0.
(TAGUM®)
Other Names:
|
|
Experimental: Nylon Non absorbable sutures
Periodontal and periimplant flaps closed with at least one suture with Nylon Non absorbable sutures, synthetic, 4-0.
(TAGUM®)
|
Periodontal and periimplant flaps closed with at least one suture with Nylon Non absorbable sutures, synthetic, 4-0.
(TAGUM®)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
healing changes around each suture material
Time Frame: 1 week, 2 weeks 1 month and 3 months after surgery.
|
To determinate the healing changes around each suture material using the Healing Index of Landry and colleagues (1988)
|
1 week, 2 weeks 1 month and 3 months after surgery.
|
|
Tensile and mechanical properties of each suture material
Time Frame: following 1 week of clinical application.
|
Evaluation of the tensile mechanical properties of each suture material using a Chatilloin TCD200 jig attachment, and tensile load will be applied to each suture at 0.05N/mm per min.
Each suture will be stretched to failure and the maximum load will be recorded in Newtons (N).
|
following 1 week of clinical application.
|
|
Biofilm formation around each suture material
Time Frame: following 1 week of clinical application.
|
To determinate the biofilm formation around each suture material using PCR
|
following 1 week of clinical application.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
complications including erythema, edema, hematoma, infection, wound dehiscence, keloid or scar tissue
Time Frame: 1 week, 2 weeks, 1 month and 3 months after surgery.
|
To determinate the presence of complications including erythema, edema, hematoma, infection, wound dehiscence, keloid or scar tissue
|
1 week, 2 weeks, 1 month and 3 months after surgery.
|
|
plaque adherence over sutures, number of sutures present and number of stable (untied) sutures
Time Frame: 1 week after surgery.
|
To determinate the plaque adherence over sutures, number of sutures present and number of stable (untied) sutures • Plaque adherence over sutures. This will be classified as following: 0: no debris or plaque present;
|
1 week after surgery.
|
|
subject satisfaction
Time Frame: 1 week and 3 months following surgery.
|
To determinate subject pain/satisfaction using a Visual Analogue Scale (VAS) at Visits 2 and 5.
The VAS will be given to the subject in order to rate the satisfaction on a scale from 0 to 10, where 10 is the highest level of pain/satisfaction.
|
1 week and 3 months following surgery.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ismael Khouly, PhD, New York University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 010-2019-PRO8
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.